.avif)
.avif)
UCB Pharma Email Format
Pharmaceutical Manufacturing
・
5,001-10,000 employees
・
Brussels, Belgium
UCB Pharma is a global biopharmaceutical company headquartered in Belgium that develops and delivers innovative therapies for severe neurological and immunological conditions.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@ucb.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1928
Headquarters
Brussels, Belgium
Revenue
$5B-$10B
FUNDING Stage
Private
Website
Key Executives
Jean-Christophe Tellier (Chief Executive Officer & Chairman of the Executive Committee), Sandrine Dufour (Executive Vice President Chief Financial Officer), Edwin Erckens (Chief Digital Technology Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of UCB Pharma?
UCB Pharma uses the first.last format, so Jane Smith would be jane.smith@ucb.com.
What are UCB Pharma's two main therapeutic areas?
UCB Pharma is focused on neurology and immunology, developing treatments for conditions such as epilepsy, Parkinson's disease, plaque psoriasis, psoriatic arthritis, and generalized myasthenia gravis across roughly 40 countries.
Which UCB Pharma immunology product has received FDA approval for multiple indications including hidradenitis suppurativa?
BIMZELX (bimekizumab-bkzx) is UCB Pharma's FDA-approved IL-17A and IL-17F inhibitor, indicated for moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and hidradenitis suppurativa in adults.
How can I find the right UCB Pharma contact for outreach to their neurology or immunology teams?
UCB Pharma employees follow the first.last@ucb.com email pattern, so once you have a name, building the address is straightforward. Tools like Clay can help you enrich and verify contact details across UCB Pharma's neurology and immunology divisions.
Who is the CEO of UCB Pharma and how long have they led the company?
Jean-Christophe Tellier has served as CEO of UCB Pharma since January 2015, also chairing the Executive Committee. He joined UCB in 2011 and previously led the company's BioBrands and Solutions division as Executive Vice President.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating